182 related articles for article (PubMed ID: 35722901)
21. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia.
Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480
[TBL] [Abstract][Full Text] [Related]
22. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
24. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
25. Increasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden.
Vikström S; Mikiver R; Lapins J; Nielsen K; Vassilaki I; Lyth J; Isaksson K; Eriksson H
Br J Dermatol; 2023 Nov; 189(6):702-709. PubMed ID: 37463416
[TBL] [Abstract][Full Text] [Related]
26. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
29. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
30. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
31. Burden of skin cancer in Colombia.
Meijs M; Herrera A; Acosta A; de Vries E
Int J Dermatol; 2022 Aug; 61(8):1003-1011. PubMed ID: 35141880
[TBL] [Abstract][Full Text] [Related]
32. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996.
Stang A; Stang K; Stegmaier C; Hakulinen T; Jöckel KH
Eur J Cancer Prev; 2001 Oct; 10(5):407-15. PubMed ID: 11711755
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
Cox NH; Jones SK; MacKie RM
Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous melanoma attributable to solar radiation in Cali, Colombia.
de Vries E; Amador JR; Rincon CJ; Uribe C; Parkin DM
Int J Cancer; 2017 May; 140(9):2070-2074. PubMed ID: 28187531
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal.
Alves da Costa F; Ramos A; Bernardo C; Cardoso Borges F; Costa Miranda A;
Sci Rep; 2023 Apr; 13(1):5641. PubMed ID: 37024631
[TBL] [Abstract][Full Text] [Related]
37. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
Leiter U; Buettner PG; Eigentler TK; Bröcker EB; Voit C; Gollnick H; Marsch W; Wollina U; Meier F; Garbe C
J Am Acad Dermatol; 2012 Jan; 66(1):37-45. PubMed ID: 21700361
[TBL] [Abstract][Full Text] [Related]
38. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
[TBL] [Abstract][Full Text] [Related]
39. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
40. Melanoma of the external ear: A population-based study.
Deep NL; Glasgow AE; Habermann EB; Kasperbauer JL; Carlson ML
Am J Otolaryngol; 2017; 38(3):309-315. PubMed ID: 28258767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
